There are 412 resources available
Discussion
Presenter: All Speakers
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Slides
Webcast
First voting
Presenter: Tony S.K. Mok
Session: Adjuvant or neoadjuvant immunotherapy or both in localised NSCLC
Resources:
Slides
Webcast
Second voting
Presenter: Tony S.K. Mok
Session: Adjuvant or neoadjuvant immunotherapy or both in localised NSCLC
Resources:
Slides
Webcast
Non-oncogene-addicted metastatic NSCLC discussion
Presenter: Solange Peters
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
Management of relapse on/after perioperative IO
Presenter: Martin Frueh
Session: Adjuvant / neoadjuvant therapy of operable NSCLC in 2023
Resources:
Slides
Webcast
The role of radiation therapy
Presenter: Cécile Le Pechoux
Session: Management of oligometastatic disease in NSCLC
Resources:
Slides
Webcast
Adjuvant only
Presenter: Enriqueta Felip
Session: Adjuvant or neoadjuvant immunotherapy or both in localised NSCLC
Resources:
Slides
Webcast
1437P - Clinical and economic burden of tissue re-biopsy (TRB) vs. tissue followed by liquid biopsy (TFLB) in metastatic non-small cell lung cancer (mNSCLC) patients
Presenter: Nicole Engel-Nitz
Session: Poster session 20
Welcome and “set the scene”
Presenter: Tony S.K. Mok
Session: Adjuvant or neoadjuvant immunotherapy or both in localised NSCLC
Resources:
Slides
Webcast